Vistin Pharma ASA: Invitation to Q3 2024 conference call

24 Oct 2024 10:00 CEST

Oslo, Norway, 24 October 2024

Vistin Pharma ASA will release its third quarter and YTD 2024 results on
Thursday 31st of October 2024. Vistin Pharma will host a conference call for all
shareholders and interested parties at the same day; Thursday 31(st) of October
at 08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in English.

The third quarter conference call will be available via web and audio through
the following access points:

Webcast: https://edge.media-server.com/mmc/p/vbrzzjjk

Telephone conference (online registration):
https://register.vevent.com/register/BI809b345192f14b6882c8bda7de2220b6

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.


 This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act

More information:
Access the news on Oslo Bors NewsWeb site